期刊文献+

高密度脂蛋白模拟肽修复肿瘤坏死因子α诱导的内皮祖细胞损伤

High density lipoprotein mimic peptide repairs the damage of endothelial progenitor cells functions induced by tumor necrosis factor α
下载PDF
导出
摘要 目的观察高密度脂蛋白模拟肽(Rev-D4F)对肿瘤坏死因子(TNF)-α诱导的内皮祖细胞凋亡和黏附的影响。方法差速贴壁法培养内皮祖细胞;吸附低度脂蛋白和结合凝集素方法鉴定内皮祖细胞;分别给予Rev-D4F(50μg/ml)和TNF-α(30ng/ml)进行处理,采用黏附测定实验和流式检测内皮祖细胞的黏附功能和凋亡情况。结果TNF-α促进内皮祖细胞凋亡,但TNF-α对内皮祖细胞黏附并没有作用,Rev-D4F预先干预能明显抑制TNF-α诱导的内皮祖细胞凋亡,提高内皮祖细胞黏附功能。结论Rev-D4F抑制TNF-α诱导的内皮祖细胞凋亡,提高内皮祖细胞黏附功能。 Objective To study the effects of high density lipoprotein mimic peptide Rev-D4F on the apoptosis and adhesion of endothelial progenitor cells(EPCs)induced by tumor necrosis factor(TNF)-α.Methods EPCs were cultured by differential time attachment and identified by adsorption of low lipoprotein and binding lectin.EPCs were treated with Rev-D4F(50μg/ml)and TNF-α(30 ng/ml)respectively,the adhesion function and apoptosis of EPCs were measured by adhesion assay and flow cytometry.Results TNF-αpromoted EPCs apoptosis,but had no effect on EPCs adhesion.Rev-D4F pretreatment significantly inhibited TNF-αinduced EPCs apoptosis and improved endothelial progenitor cell adhesion function.Conclusions Rev-D4F could inhibit the apoptosis of EPCs induced by TNF-αand improve the adhesion function of EPCs.
作者 王凤娇 高翔 孔淑琦 张建林 刘祺 尹航 王梦洁 王晓丹 牟青杰 杨娜娜 WANG Feng-Jiao;GAO Xiang;KONG Shu-Qi(Experimental Center for Medical Research,Weifang Medical University,Weifang 261000,Shandong,China)
出处 《中国老年学杂志》 CAS 北大核心 2019年第15期3729-3731,共3页 Chinese Journal of Gerontology
基金 国家自然科学基金(81600360) 山东省科技发展计划(2014GSF118105) 山东省高等学校科技计划项目(J14LK03,J8KA272)
关键词 高密度脂蛋白 肿瘤坏死因子 内皮祖细胞 High density lipoprotein(HDL) Tumor necrosis factor(TNF)-α Endothelial progenitor cells(EPCs)
  • 相关文献

参考文献1

二级参考文献23

  • 1Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
  • 2Schatteman GC, Dunnwald M, Jiao C. Biology of bone marrow-derived endothelial cell precursors. Am J Physiol Heart Circ Physiol2007; 292: H1-H18.
  • 3Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F, De Buyzere ML, Gillebert TC, Plum J, Vandekerckhove B. Endothelial outgrowth cells are not derived from CD133 cells or CD45 hematopoietic precursors. Arterioscler Thromb Vasc Biol 2007; 27: 1572-1579.
  • 4Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
  • 5Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71-77.
  • 6Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park VB. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vase BioI 2004; 24: 288-293.
  • 7Eggermann J, Kliche S, Jarmy G, Hoffmann K, MayrBeyrle U, Debatin , Waltenberger J, Beltinger C. Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiovas Res 2003; 58: 478-486.
  • 8Yang N, Li D, Jiao P, Chen B, Yao S, Sang H, Yang M, Han J, Zhang Y, Qin S. The characteristics of endothelial progenitor cells derived from mononuclear cells of rat bone marrow in different culture conditions. Cytotechnology 2011; 63(3): 217-226.
  • 9Miller-Kasprzak E, Jagodzinski PP. Endothelial progenitor cells as a new agent contributing to vascular repair. Arch Immunol Ther Exp (Warsz) 2007; 55(4): 247-259.
  • 10Loomans CJM, de Koning EJP, Staal FJT, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ. Endothelial progenitor cell dysfunction-a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004; 53: 195-199.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部